Storia in 2 fonti

Congo seeks US monoclonal antibody for Bundibugyo Ebola strain

DR Congo is exploring emergency treatment options, including an experimental US-developed antibody, as health officials race to contain the Ebola outbreak in the country’s east.

Raccontata da

theeastafrican.co.ke

independent.co.uk

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

theeastafrican.co.keStai leggendo3 mesi fa

Congo seeks US monoclonal antibody for Bundibugyo Ebola strain

DR Congo is exploring emergency treatment options, including an experimental US-developed antibody, as health officials race to contain the Ebola outbreak in the country’s east.

originale

independent.co.uk3 mesi fa

All the vaccines and treatments currently in development for Ebola

Unlike the more common Zaire strain, there are no approved medical interventions for deadly Bundibugyo

Leggi questa versione → originale

Timeline cronologica

mercoledì 27 maggio 2026·theeastafrican.co.ke
Congo seeks US monoclonal antibody for Bundibugyo Ebola strain
DR Congo is exploring emergency treatment options, including an experimental US-developed antibody, as health officials race to contain the Ebola outbreak in the country’s east.
sabato 30 maggio 2026·independent.co.uk
All the vaccines and treatments currently in development for Ebola
Unlike the more common Zaire strain, there are no approved medical interventions for deadly Bundibugyo